Block of c-myc expression by antisense oligonucleotides inhibits proliferation of human thyroid carcinoma cell lines

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 119-126

  Cerutti, Janete ^a   Trapasso, Francesco ^b   Battaglia, Caterina ^b   Zhang, Li ^a   Martelli, Maria Luisa ^b   Visconti, Roberta ^a   Berlingieri, Maria Teresa ^a   Fagin, James A ^c   Santoro, Massimo ^a   Fusco, Alfredo ^b,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE;

ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; THYROID CARCINOMA;

CELL DIVISION; GENES, MYC; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 9044247864     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Cole, M. D. The myc oncogene: its role in transformation and differentiation. Annu. Rev. Genet., 20: 361-384, 1986.
2. Luscher, B., and Eisenman, R. N. New light on myc and myb. I. Myc. Genes & Dev., 4: 2025-2035, 1990.
3. Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M., Waters, C. M., Penn, L. Z., and Hancock, D. C. Induction of apoptosis in fibroblasts by c-myc protein. Cell, 69: 119-128, 1992.
4. Shi, Y., Glynn, J. M., Guilbert, L. J., Cotter, T. G., Bissonnette, R. P., and Green, D. R. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science (Wash. DC), 257: 212-214, 1992.
5. 1 Mol. Cell. Biol., 8: 1614-1624, 1988.
6. Miner, J. H., and Wold, B. J. c-Myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell. Biol., 11: 2842-2851, 1991.
7. Abrams, H D., Rohrschneider, L. R., and Eisenman, R. N. Nuclear location of the putative transforming protein of avian myelocytomatosis virus. Cell. 29: 427-439, 1982.
8. Heaney, M. L., Pierce, J., and Parson, J. T. Site-directed mutagenesis of gag-myc gene of avian myelocytomatosis virus 29: biological activity and intracellular localization of structurally altered proteins. J. Virol., 60: 167-176, 1986.
9. Stone, J., Lange, T., De Ramsay, G., Jakobovits, J., Bishop, J. M., Varmus, H. E., and Lee, W. M. F. Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol. Cell. Biol., 7: 1697-1709, 1987.
10. Lech, K., Anderson, K., and Brent, R. DNA-bound Fos proteins activate transcription in yeast. Cell. 52: 179-184, 1988.
11. Kato, G. J., Barret, J., Villa-Garcia, M., and Dang, C. V. An Amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol. Cell. Biol., 10: 5914-5920, 1990.
12. Golemis, E. A., and Brent, R. Fused protein domains inhibit DNA binding by Lex A. Mol. Cell. Biol., 12: 3006-3014, 1992.
13. Blackwood, E. M., and Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with myc. Science (Wash. DC), 251: 1211-1217, 1991.
14. Prendergast, G. C., Lawe, D., and Ziff, E. B. Association of myn, the murine homolog of Max, with c-Myc stimulates methylation-sensitive DNA binding and Ras cotransformation. Cell, 61: 1187-1197, 1991.
15. Alitalo, K., and Schwab, M. Oncogene amplification in tumor cells. Adv. Cancer Res., 47: 235-281, 1986.
16. Barbacid, M. Oncogenes and human cancer: cause or consequences? Carcinogenesis (Lond.), 7: 1037-1042, 1986.
17. Little, C D., Nau, M. M., Carney, D. N , Gazdar, A. F., and Minna, J. D. Amplification and expression of c-myc oncogene in human lung cancer cell lines. Nature (Lond.), 306: 194-196, 1983.
18. Fusco, A., Berlingien, M. T., Portella, G., Di Fiore, P. P., Grieco, M., and Vecchio, G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncosenes. Mol. Cell. Biol., 7: 3365-3370, 1987.
19. Terrier, P., Sheng, Z. M., Schlumberger, M., Tubiana, M., Caillou, B., Travagli, J. P , Fragu, P., Parmentier, C., and Riou, G. Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br. J. Cancer, 57: 43-47, 1988.
20. Tanaka, J , Ogura, T., Sato, H., and Hatano, M. Establishment and biological characterization of an in vivo human cytomegalovirus latency model. Virology, 161: 62-72, 1987.
21. Estour, B., Van Herle, A. J., Juillard, G. T., Totanes, T. L., Sparkes, R. S., Giuliano, A. E., and Klandorf, H. Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch. B Cell Pathol., 57: 167-174, 1989.
22. Pang, X J., Hershman, M., Chung, M., and Pekary, A. E. Characterization of tumor necrosis factor-α receptors in human and rat thyroid cells and regulation of the receptors by thyrotropin. Endocrinology. 125: 1783-1788, 1989.
23. Fagin, J A., Matsuo, K., Karmakar, A., Chen, D. L., Tang, S. H., and Koeffier, H. P. High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J. Clin. Invest., 91: 179-184, 1993.
24. Zeki, K., Nakano, Y., Inokuchi, N., Watanabe, K., Morimoto, I., Yamashita, U., and Eto, S. Autocrine stimulation of interleukin-1 in the growth of human thyroid carcinoma cell line NIMI. J. Clin. Endocrinol. & Metab. 76: 127-133, 1991.
25. Fabien, N., Fusco, A., Santoro, M., Barbier, Y., Dubois, P. M., and Paulin, C. Description of a human papillary thyroid carcinoma cell line: morphologic study and expression of tumoral markers. Cancer (Phila.), 73: 2206-2212, 1994.
26. Curcio, F., Ambesi-Impiombato, F. S., Perrella, G., and Coon, H. G. Long-term culture and functional characterization of follicular cells from adult normal human thyroids. Proc. Natl. Acad. Sci. USA, 91: 9004-9008, 1994.
27. Macpherson, I., and Montagnier, I. Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology, 23: 291-294, 1964.
28. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
29. Nishikura, K., Rushdi, A. A., Erikson, J., Watt, R., Rovera, G., and Croce, C. M. Differential expression of the normal and of the translocated human c-myc oncogenes in B cells. Proc. Natl. Acad. Sci. USA, 80: 4822-4826, 1983.
30. Tokunaga, K., Taniguchi, H., Yoda, K., Shimizu, M., and Sakyama, S. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal B-actin mRNA. Nucleic Acids Res., 14: 2829-2836, 1986.
31. Francis-Lang, H., Zannini, M., Berlingieri, M. T., Fusco, A., and Di Lauro, R. Multiple mechanisms of interference between transformation and differentiation in thyroid cells. Mol. Cell. Biol. 12: 5793-5800, 1992
32. Harlow, E., and Lane, D. Antibodies: A Laboratory Manual, Immunobloning, pp. 471-511. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
33. Holt, J. T., Redner, R. L., and Nienhuis, A. W. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol. Cell Biol., 8: 963-973, 1988.
34. Collins, J. F., Herman, P., Schuch, C., and Beghj, G. C., Jr. c-myc antisense oligonucleotides inhibit the colony-forming capacity of Colo 320 colonic carcinoma cells. J. Clin. Invest., 89, 1523-1527, 1992.
35. Stein, C. A., Subasinge, C., Shinozuka, K., and Cohen, J. S Physiochemical properties of phosphorothioate oligodeoxynucleotide. Nucleic Acids Res., 16: 3209-3221, 1988.
36. Iacovelli, L., Falasca, M., Valitutti, S., D'Arcangelo, D., and Corda, D. Glycerophosphoinositol 4-phosphate, a putative endogenous inhibitor of adenyl cyclase. J. Biol. Chem., 268: 20402-20407, 1993.
37. Marcu, K. B., Bossone, S. A., and Patel, A. J. myc function and regulation. Annu. Rev. Biochem. 61: 809-860, 1992.
38. Hedinger, C., Williams, E. D., and Sobin, L. H. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer (Phila.), 63: 908-911, 1989.
39. Haugen, D. R. F., Akslen, L. A., Varhaug, J. E., and Lillehaug, J R. Demonstration of a TGF-α-EGF receptor autocrine loop and c-myc protein over-expression in papillary carcinomas. Int. J. Cancer, 55: 37-43, 1993.
40. 1 phase arrest induced by RB protein but not by p53. Nature (Lond.), 360: 177-179, 1992.
41. Sawyers, C. L., Callahan, W., and Witte, O. N. Dominant negative MYC blocks transformation by ABL oncogenes. Cell, 70: 901-910, 1992.
42. Sklar, M. D., Thompson, E., Welsh, M. J., Liebert, M., Harney, J., Grossman, H. B., Smith, M., and Prochownik, E. V. Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene transformed NIH 3T3 cells. Mol. Cell. Biol., 11: 3699-3710, 1991.
43. Fusco, A., Berlingieri, M. T., Portella, G., Di Fiore, P. P., Grieco, M., and Vecchio, G. One- and two-step transformations of rat thyroid epithelial cells by retroviral oncogenes. Mol. Cell. Biol. 7: 3365-3370, 1987.
44. Berlingieri, M. T., Portella, G., Grieco, M., Santoro, M., and Fusco, A. Cooperation between polyoma virus middle T gene and the human c-myc oncogene on a rat thyroid epithelial differentiated cell line: a model of in vitro progression. Mol. Cell. Biol., 8: 226-230, 1988.
45. Lemoine, N. R., Mayall, E. S., Wyillie, F. S., Williams, E. D., Goyns, M., Stringer, B , and Wynford-Thomas, D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene, 4: 159-164, 1989,
46. Namba, H., Gutman, R. A., Matsuo, K., Alvarez, A., and Fagin, J. A. H-ras proto-oncogene mutations in human thyroid neoplasms. J. Clin. Endocrinol. & Metab., 71: 223-229, 1990.
47. Suarez, H G., du Villard, J. A., Caillou, B., Schlumberger, M., Tubiana, M., Parmentier, C., and Monier, R. Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene, 2: 403-406, 1988.
48. Santoro, M., Carlomagno, F., Hay, I. D., Herrmann, M. A., Melillo, R., Bongarzone, I., Pierotti, M. A. Della Porta, G., Berger, N., Peix, J. L., Paulin, C., Fabien, N., Grieco, M., Vecchio, G., Jenkins, R. B., and Fusco, A. RET oncogene activation in human thyroid neoplasms is restricted to the papillary carcinoma subtype. J. Clin. Invest. 89: 1517-1522, 1992.
49. Fagin, J. A., Molecular pathogenesis of human thyroid neoplasms. In: J. H. Oppenheimer (ed.), Thyroid Today, Vol. 17, No. 3, pp. 1-7, 1994
50. Viglietto, G., Chiappetta, G , Martinez-Tello, F. J., Fukunaga, F. H., Tallini, G., Rigopoulou, D., Visconti, R., Mastro, A., Santoro, M., and Fusco, A. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene, 11: 1207-1210, 1995.